Bonafede, Machaon
Mehta, Rina
Kim, Gilwan
Sruti, Ila
Tian, Marc
Pelletier, Corey
Goldfarb, Neil
Article History
Accepted: 19 September 2020
First Online: 13 October 2020
Declarations
:
: This study was funded by Celgene, a Bristol-Myers Squibb company.
: CP is employed by Bristol-Myers Squibb Company; RM and MT were employed by Bristol-Myers Squibb Company at the time the study was conducted. GK is employed by IBM Watson Health as a consultant and received funding from Bristol-Myers Squibb Company to conduct this study; MB and IS were employed by IBM Watson Health at the time the study was conducted. NG is a paid consultant of Bristol-Myers Squibb Company.
: All database records are statistically de-identified and certified to be fully compliant with US patient confidentiality requirements set forth in the Health Insurance Portability and Accountability Act of 1996. Because this study used only de-identified patient records and did not involve the collection, use, or transmittal of individually identifiable data, Institutional Review Board approval to conduct this study was not necessary.
: Not applicable.
: Not applicable.
: The data that support the findings of this study are available from IBM Watson Health. Restrictions apply to the availability of these data, which were used under license for this study.
: Not applicable.
: All authors contributed to the study conception and design. Material preparation and data analysis were performed by Gilwan Kim and Ila Sruti. All authors contributed to the development of the first draft and read and approved the final manuscript.